Clinical trial
Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
NCT00004400 is registered in ClinicalTrials.gov with Charles Drew University of Medicine and Science as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
- Lead sponsor
- Charles Drew University of Medicine and Science
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 1997
- Completion date
- September 30, 2001
- Enrollment
- 56 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.